13 completed, 3 not yet recruiting, 2 recruiting, 2 unknown. 8 Phase 2, 7 Not applicable, 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 6, Not yet recruiting 1, Recruiting 1 |
| Not applicable | 7 | Completed 5, Unknown 2 |
| Phase 3 | 3 | Not yet recruiting 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Subcutaneous Fat: new trials by email Literature Review of Subcutaneous Fat trials Research Report on Subcutaneous Fat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat CBL-514 Injection - Subcutaneous Fat | Phase 2 | Not yet recruiting | Caliway Biopharmaceuticals Co., Ltd. | 250 | 2027-02-01 | 2026-10-20 |
| A Study to Evaluate the Maintenance of Efficacy and Long-term Safety of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1) CBL-514 Injection, 0.9 % sodium chloride - Subcutaneous Fat | Phase 3 | Not yet recruiting | Caliway Biopharmaceuticals Co., Ltd. | 300 | 2026-12-01 | 2026-10-19 |
| A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 ) CBL-514 Injection, 0.9% Sodium Chloride - Subcutaneous Fat | Phase 3 | Not yet recruiting | Caliway Biopharmaceuticals Co., Ltd. | 320 | 2026-10-01 | 2026-10-20 |
| A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat CBL-514 Injection, 0.9% Sodium Chloride - Subcutaneous Fat | Phase 3 | Recruiting | Caliway Biopharmaceuticals Co., Ltd. | 320 | 2026-09-01 | 2026-10-19 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat CBL-514 Injection, 0.9% Sodium Chloride - Subcutaneous Fat | Phase 2 | Recruiting | Caliway Biopharmaceuticals Co., Ltd. | 250 | 2026-06-01 | 2026-10-20 |
| A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat. CBL-514 injection, CBL-A1 Injection, CBL-A2 Injection - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 173 | 2023-11-10 | 2024-12-05 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat CBL-514 Injection, 0.9% Sodium Chloride - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 107 | 2023-05-30 | 2024-07-22 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2) CBL-514 Injection, Placebo - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 75 | 2022-02-14 | 2023-04-24 |
| A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers CBL-514 - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 10 | 2022-02-11 | 2026-05-22 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1) CBL-514 - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 25 | 2020-12-09 | 2024-08-09 |
| Feasibility of Producing the Appearance of a Gluteal Lift Post Cryolipolysis ZELTIQ thermoelectric device - Subcutaneous Fat | Not applicable | Unknown | Riverchase Dermatology | 10 | 2020-07-15 | 2020-10-19 |
| A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat CBL-514 - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 43 | 2020-02-03 | 2021-01-08 |
| Diagnostic Ultrasound for Measuring Fat of the Body LOGIQ P6 Diagnostic Ultrasound - Subcutaneous Fat | Not applicable | Completed | Northwestern University | 40 | 2019-03-20 | 2023-09-28 |
| A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers CBL-514, placebo, CBL-514 - Subcutaneous Fat | Phase 1 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 40 | 2018-11-27 | 2021-01-07 |
| Cryolipolysis on Localized Adiposity Cryolipolysis - Subcutaneous Fat | Not applicable | Unknown | Federal University of Health Science of Porto Alegre | 28 | 2017-05-25 | 2017-05-24 |
| Effects of Ultrasound Cavitation Focused on Located Adiposity LIPOFOCUS - Subcutaneous Fat | Not applicable | Completed | Federal University of Health Science of Porto Alegre | 28 | 2015-01-01 | 2015-09-02 |
| Usefulness of Non-invasive Radiofrequency Therapy for Facial Contouring Noninvasive Radiofrequency TruSculpt - Subcutaneous Fat | Not applicable | Completed | Kangbuk Samsung Hospital | 21 | 2013-11-01 | 2015-07-31 |
| Evaluation of the Safety and Precursors of Efficacy 1064nm Laser, 940nm Laser - Subcutaneous Fat | Not applicable | Completed | Cynosure, Inc. | 10 | 2013-06-01 | 2020-10-27 |
| Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection) Deoxycholic acid Injection, Placebo - Subcutaneous Fat | Completed | Allergan | 201 | 2012-02-14 | 2018-09-24 | |
| Clinical Investigation of Non Invasive Fat Reduction Diode Laser, YAG laser - Subcutaneous Fat | Not applicable | Completed | Cynosure, Inc. | 8 | 2012-01-01 | 2020-10-28 |
Obesity (1)
Body Weight (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Overweight (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Sodium Chloride (6) · Deoxycholic Acid (1) · Lasers (1) · Lasers, Semiconductor (1) · Lasers, Solid-State (1)
Caliway Biopharmaceuticals Co., Ltd. (12) · Cynosure, Inc. (2) · Federal University of Health Science of Porto Alegre (2) · Allergan (1) · Kangbuk Samsung Hospital (1) · Northwestern University (1) · Riverchase Dermatology (1)
United States (11) · Australia (7) · Canada (2) · Brazil (1) · Germany (1)
Anne Sheu (9) · Beta Bowen (1) · Cinara LS Lima (1) · Leyda R Bowes, MD (1) · Murad Alam, MD (1) · Patric Krantz (1) · Patricia Krantz (1) · Rodrigo DM Plentz, PhD (1) · Won-Serk Kim, M.D., Ph.D. (1)